{"id":"https://openalex.org/W7225159266","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0914","title":"914 Dual-antigen targeting via a PMPC-engineered bispecific ADC overcomes tumor heterogeneity and enhances anti-tumor efficacy in advanced ovarian cancer","display_name":"914 Dual-antigen targeting via a PMPC-engineered bispecific ADC overcomes tumor heterogeneity and enhances anti-tumor efficacy in advanced ovarian cancer","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225159266","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0914"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0914","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0914","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0914","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1033.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A1033.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160444112","display_name":"Jie Ren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jie Ren","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160528433","display_name":"Sreedhari Bulusu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sreedhari Bulusu","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120257182","display_name":"Srinivasarao Ramisetty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srinivasarao Ramisetty","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029118172","display_name":"Chloe E Jepson","orcid":"https://orcid.org/0000-0003-4861-7942","observed_orcids":["https://orcid.org/0000-0003-4861-7942"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chloe E Jepson","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160452349","display_name":"Arina Thai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arina Thai","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160465899","display_name":"Kailey N Lamont","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kailey N Lamont","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160440135","display_name":"Kevin N Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin N Liu","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160416147","display_name":"Naoki Hama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naoki Hama","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160406449","display_name":"Hunter S Dickens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hunter S Dickens","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111064838","display_name":"Yoshiko N Kamata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoshiko N Kamata","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083408464","display_name":"Masakazu Kamata","orcid":"https://orcid.org/0000-0003-0323-3742","observed_orcids":["https://orcid.org/0000-0003-0323-3742"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masakazu Kamata","raw_affiliation_strings":["The University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I32389192"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1033","last_page":"A1033"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.6532999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.6532999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.29829999804496765,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0210999995470047,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibody-drug-conjugate","display_name":"bispecific antibody-drug conjugate","score":0.9700000286102295},{"id":"https://openalex.org/keywords/dual-antigen-targeting","display_name":"dual antigen targeting","score":0.847000002861023},{"id":"https://openalex.org/keywords/poly-2-methacryloyloxyethyl-phosphorylcholine","display_name":"poly(2-methacryloyloxyethyl phosphorylcholine)","score":0.9020000100135803},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.6660000085830688},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5550000071525574},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.6710000038146973},{"id":"https://openalex.org/keywords/deruxtecan","display_name":"deruxtecan","score":0.9559999704360962},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.4819999933242798},{"id":"https://openalex.org/keywords/intratumoral-delivery","display_name":"intratumoral drug delivery","score":0.6899999976158142},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7229999899864197},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.7440000176429749},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7879999876022339},{"id":"https://openalex.org/keywords/off-target-toxicity","display_name":"off-target toxicity","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6952999830245972},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6460999846458435},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5819000005722046},{"id":"https://openalex.org/C3018028425","wikidata":"https://www.wikidata.org/wiki/Q15917291","display_name":"Tumor heterogeneity","level":3,"score":0.5792999863624573},{"id":"https://openalex.org/C2780084626","wikidata":"https://www.wikidata.org/wiki/Q11793790","display_name":"Ovarian tumor","level":4,"score":0.34540000557899475},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.295199990272522},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2912999987602234},{"id":"https://openalex.org/C2908651487","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinomas","level":5,"score":0.2628999948501587},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.2531999945640564},{"id":"https://openalex.org/C2992773878","wikidata":"https://www.wikidata.org/wiki/Q7645976","display_name":"Epithelial ovarian cancer","level":4,"score":0.24770000576972961}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0914","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0914","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0914","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1033.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0914","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0914","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0914","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1033.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W7225159266.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400839724","https://openalex.org/W7225161620","https://openalex.org/W7117298452","https://openalex.org/W1975263958","https://openalex.org/W7117312842","https://openalex.org/W3153518049","https://openalex.org/W7223906971","https://openalex.org/W7030608619","https://openalex.org/W4414350029","https://openalex.org/W4388080187"],"abstract_inverted_index":{"Background":[0],"High-grade":[1],"serous":[2],"ovarian":[3,109,244],"cancer":[4,110,245],"(HGSOC)":[5],"kills":[6],"more":[7],"women":[8],"than":[9,207],"any":[10],"other":[11],"gynecologic":[12],"malignancy.":[13],"Over":[14],"70%":[15],"of":[16,94],"patients":[17],"relapse":[18],"after":[19],"first-line":[20],"therapy,":[21],"and":[22,63,98,113,125,168,185,192,209,228,236,261,270,308],"no":[23],"treatment":[24],"currently":[25],"achieves":[26],"durable":[27],"control":[28,265],"in":[29,86,197,233,297],"the":[30,159,234,275,313],"platinum-resistant":[31,332],"setting.":[32],"Antibody-drug":[33],"conjugates":[34],"(ADCs)":[35],"have":[36],"generated":[37],"excitement":[38],"but":[39],"remain":[40],"constrained":[41],"by":[42,221],"four":[43,83,114],"interrelated":[44],"failures:":[45],"single-antigen":[46],"targeting":[47,76],"allows":[48],"tumor":[49,61,118,170,264],"escape":[50],"through":[51,163,302,339],"antigen":[52,300],"downregulation;":[53],"off-target":[54,231],"toxicity":[55,284],"limits":[56],"dosing;":[57],"poor":[58],"pharmacokinetics":[59],"reduce":[60],"exposure;":[62],"inadequate":[64],"penetration":[65],"leaves":[66],"disseminated":[67],"micrometastases":[68],"untreated.":[69],"We":[70,90],"asked":[71],"whether":[72],"combining":[73],"bispecific":[74,95,135,276],"antibody-drug":[75],"with":[77,104,123,138,327],"polymer-shielded":[78],"delivery":[79,194],"could":[80],"resolve":[81],"all":[82],"simultaneously":[84],"\u2014":[85,127,132,211,216,315],"a":[87,92,101,322],"single":[88,289],"construct.Methods":[89],"screened":[91],"library":[93],"antibodies":[96],"(bsAbs)":[97],"identified":[99],"UAB28-3,":[100],"lead":[102],"candidate":[103],"confirmed":[105],"binding":[106],"across":[107,217],"six":[108],"cell":[111,183,219,246],"lines":[112,184,220],"independent":[115],"HGSOC":[116,182,218],"patient-derived":[117,186],"samples.":[119],"UAB28-3":[120],"was":[121,179],"conjugated":[122],"MMAE":[124],"DXd":[126],"two":[128,212],"membrane-permeable,":[129],"bystander-killing":[130],"payloads":[131],"to":[133,239],"generate":[134],"ADCs":[136,215,250,296],"(bsADCs)":[137],"mechanistically":[139],"distinct":[140],"cytotoxic":[141],"mechanisms.":[142],"To":[143],"address":[144],"systemic":[145,283,306],"delivery,":[146],"we":[147],"applied":[148],"our":[149],"patented":[150],"poly(2-methacryloyloxyethyl":[151],"phosphorylcholine)":[152],"(PMPC)":[153],"polymer":[154,173],"engineering":[155,224,280],"platform,":[156],"which":[157],"shields":[158],"ADC":[160,272,324],"during":[161],"circulation":[162],"an":[164],"anti-fouling":[165],"surface":[166],"coating":[167],"enables":[169],"microenvironment":[171],"(TME)-triggered":[172],"removal":[174],"via":[175],"MMP-2/9-cleavable":[176],"linkers.":[177],"Efficacy":[178],"evaluated":[180],"against":[181],"xenograft":[187,198,247],"(PDX)":[188],"tumors;":[189],"pharmacokinetics,":[190],"biodistribution,":[191],"intratumoral":[193,254],"were":[195],"assessed":[196],"mouse":[199],"models.Results":[200],"UAB28-3-based":[201],"bsADCs":[202],"exceeded":[203],"100-fold":[204],"greater":[205,253],"potency":[206],"T-DXd":[208],"T-MMAE":[210],"leading":[213,294],"clinical-stage":[214],"IC50.":[222],"PMPC":[223,279],"doubled":[225],"plasma":[226],"half-life":[227],"substantially":[229],"reduced":[230],"accumulation":[232],"liver":[235],"spleen":[237],"compared":[238],"non-engineered":[240],"controls.":[241],"In":[242],"human":[243],"models,":[248],"PMPC-engineered":[249,290],"achieved":[251],"34%":[252],"drug":[255,310],"signal":[256],"at":[257,285],"24":[258],"hours":[259],"post-injection":[260],"produced":[262],"superior":[263],"over":[266],"both":[267],"unmodified":[268],"bsADC":[269,291],"monospecific":[271],"comparators.":[273],"Neither":[274],"format":[277],"nor":[278],"introduced":[281],"detectable":[282],"therapeutic":[286],"doses.Conclusions":[287],"A":[288],"construct":[292],"outperforms":[293],"clinical":[295],"potency,":[298],"overcomes":[299],"heterogeneity":[301],"dual":[303],"targeting,":[304],"doubles":[305],"circulation,":[307],"concentrates":[309],"selectively":[311],"within":[312],"TME":[314],"without":[316],"added":[317],"toxicity.":[318],"These":[319],"findings":[320],"establish":[321],"new":[323],"design":[325],"principle":[326],"direct":[328],"translational":[329],"relevance":[330],"for":[331],"HGSOC.":[333],"Clinical":[334],"development":[335],"is":[336],"being":[337],"advanced":[338],"NanoBridge":[340],"Therapeutics,":[341],"Inc.":[342]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}